{"nct_id":"NCT04060342","title":"GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma","status":"TERMINATED","status_verified_date":"2022-08","start_date":"2019-08-13","start_date_type":"ACTUAL","primary_completion_date":"2022-04-11","primary_completion_date_type":"ACTUAL","completion_date":"2022-04-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GOSS"]}